Live Breaking News & Updates on Membrane Lipid Therapy

Stay updated with breaking news from Membrane lipid therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma

140 patients have been recruited at sites in Spain, Italy, France and United Kingdom.The open readout of the trial is expected by late 2024.Laminar aims to ....

United States , United Kingdom , Pablo Escrib , Clinical Operations At Laminar Pharmaceuticals , Health Solutions , Laminar Pharmaceuticals Sa , Data Monitoring Committee , Laminar Pharmaceuticals , European Commission Grant , Clinical Operations , Conditional Marketing Authorization , Independent Data Monitoring Committee , Membrane Lipid Therapy ,